Intellipharmaceutics International
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Intellipharmaceutics International generated cash of -$6,926,796, which is more than the previous year. Cash used in financing activities reached the amount of $7,328,420 last year. Net change in cash is therefore $263,570.
Cash Flow
| 2012 | -7.65M | -1.03M | 4.36M |
|---|---|---|---|
| 2013 | -6.92M | -122.01K | 7.32M |
IPCIF Cash Flow Statement (2013 – 2014)
| 2014 | 2013 | |
|---|---|---|
Cash at beginning of period | 497.01K | 4.81M |
Operating activities | ||
Net income | -11.49M | -6.13M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||
Depreciation and amortization | 396.81K | 452.30K |
Stock-based compensation expense | 1.15M | 2.32M |
| Deferred income tax benefit | 1.15M | 2.32M |
| Changes in operating assets and liabilities: | ||
Accounts receivable, net | -1.47M | 605 |
Inventories | 0 | 0 |
Accounts payable | 0 | 0 |
Cash generated by operating activities | -6.92M | -7.65M |
Investing activities | ||
Purchases Of Investments | 0 | 0 |
Investments In Property Plant And Equipment | -122.01K | -1.03M |
Acquisitions Net | 0 | 0 |
Cash generated by investing activities | -122.01K | -1.03M |
Financing activities | ||
Common Stock Issued | 6.19M | 5M |
Payments for dividends | 0 | 0 |
Repurchases of common stock | 0 | 0 |
Repayments of term debt | -49.98K | -44.36K |
Cash used in financing activities | 7.32M | 4.36M |
Net Change In Cash | 263.57K | -4.32M |
Cash at end of period | 760.58K | 497.01K |
| Data source | Data source |